$LXRX
Lexicon Pharmaceuticals, Inc.
XNAS•Health Care•Pharmaceutical Preparations
$2.04
▲+0.49%+$0.010
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateLexicon Pharmaceuticals, Inc.
XNAS•Health Care•Pharmaceutical Preparations
Why is LXRX up today? It is at $2.04 (+0.00%), and our scanner flagged it 55 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment LXRX spikes, and full due diligence on LXRX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $LXRX 55 times in the last 30 days. Create a free account to track $LXRX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on LXRX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for LXRX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
From the trading subreddits (WallStreetBets, r/stocks and more). Retail chatter, not a signal. Do your own research.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Debbane Raymond Director | Other | 89K 0.02% of company | added 4.7% | 2.00M | n/a | Jun 3, 26 |
Amouyal Philippe Director | Other | 89K 0.02% of company | added 31% | 374K | n/a | Jun 3, 26 |
Barker Sam L Director | Other | 89K 0.02% of company | added 72% | 214K | n/a | Jun 3, 26 |
Cheung Ivan Director | Other | 89K 0.02% of company | n/a | 89K | n/a | Jun 3, 26 |
Sobecki Christopher J Director | Other | 89K 0.02% of company | added 44% | 293K | n/a | Jun 3, 26 |
Sullivan Diane E. Director | Other | 89K 0.02% of company | added 100% | 126K | n/a | Jun 3, 26 |
Swain Judith L Director | Other | 89K 0.02% of company | added 100% | 174K | n/a | Jun 3, 26 |
Artal Participations S.A R.L. Director | Other | 20.42M 4.6% of company | added 13% | 175.16M | n/a | Apr 30, 26 |
Exton Michael Officer | Sold (automatic/other) | -205K 0.05% of company | sold 41% | 298K | $301K at $1.47 | Feb 28, 26 |
Exton Michael Officer | Other | 503K 0.1% of company | n/a | 503K | n/a | Feb 28, 26 |
Coiante Scott M Officer | Sold (automatic/other) | -55K 0.01% of company | sold 34% | 105K | $81K at $1.47 | Feb 28, 26 |
Coiante Scott M Officer | Other | 160K 0.04% of company | n/a | 160K | n/a | Feb 28, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on LXRX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for LXRX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
LXRX last traded at $2.04, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Lexicon Pharmaceuticals, Inc. (LXRX) is next expected to report earnings on Thursday, November 5, 2026, about 48 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The LXRX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged LXRX 55 times in the last 30 days.
LXRX (Lexicon Pharmaceuticals, Inc.) trades on XNAS, with a market cap of about $899M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge LXRX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$LXRX discussion
Sign in to ask a question or join the discussion.